Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/10306
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | restrictedAccess | - |
dc.contributor.author | Jevtić, Verica | - |
dc.contributor.author | Pesic, Milica | - |
dc.contributor.author | Radic G. | - |
dc.contributor.author | Vukovic, Nenad | - |
dc.contributor.author | Sukdolak S. | - |
dc.contributor.author | Klisuric, Olivera | - |
dc.contributor.author | Podolski-Renic A. | - |
dc.contributor.author | Tanic N. | - |
dc.contributor.author | Trifunović, Srećko | - |
dc.date.accessioned | 2021-04-20T15:24:53Z | - |
dc.date.available | 2021-04-20T15:24:53Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0022-2860 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/10306 | - |
dc.description.abstract | The new coumarine derivative, 4-hydroxy-3-(1-(p-tolylimino)ethyl)-2H- chromen-2-one, and corresponding palladium(II) complex have been synthesized and characterized by microanalysis, infrared, 1H and 13C NMR spectroscopy. The proposed structure of the complex was confirmed on the basis of an X-ray structural study. In vitro antitumor activity for the ligand and complex was investigated. © 2013 Elsevier B.V. All rights reserved. | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.source | Journal of Molecular Structure | - |
dc.title | Synthesis, characterization and cytotoxicity of a new palladium(II) complex with a coumarin-derived ligand. Crystal structure of 4-hydroxy-3-(1-(p- tolylimino)ethyl)-2H-chromen-2-one-palladium(II) complex | - |
dc.type | article | - |
dc.identifier.doi | 10.1016/j.molstruc.2013.03.013 | - |
dc.identifier.scopus | 2-s2.0-84875404406 | - |
Appears in Collections: | Faculty of Science, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.